Global Antifungal infection Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150145
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.

Scope of the Report:

The global Antifungal infection Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antifungal infection Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Antifungal infection Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antifungal infection Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Scynexis

Sanofi-Aventis

Pfizer

Novartis

Merck & Co

Kramer Laboratories

Johnson & Johnson

ID Sigma-Aldrich Corporation

Glenmark Pharmaceuticals

Glaxosmithkline

Enzon Pharmaceuticals

Bayer Healthcare

Astellas Pharma

Asperqillus

Alternaria

Abbott Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Polyenes

Echinocandins

Azoles

Allylamines

Other Drug types

Market Segment by Applications, can be divided into

Powders

Pastes

Ointments

Drugs

Other Applications

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Antifungal infection Therapeutics Market Overview

1.1 Product Overview and Scope of Antifungal infection Therapeutics

1.2 Classification of Antifungal infection Therapeutics by Types

1.2.1 Global Antifungal infection Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Antifungal infection Therapeutics Revenue Market Share by Types in 2017

1.2.3 Polyenes

1.2.4 Echinocandins

1.2.5 Azoles

1.2.6 Allylamines

1.2.7 Other Drug types

1.3 Global Antifungal infection Therapeutics Market by Application

1.3.1 Global Antifungal infection Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Powders

1.3.3 Pastes

1.3.4 Ointments

1.3.5 Drugs

1.3.6 Other Applications

1.4 Global Antifungal infection Therapeutics Market by Regions

1.4.1 Global Antifungal infection Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antifungal infection Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Antifungal infection Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Scynexis

2.1.1 Business Overview

2.1.2 Antifungal infection Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Scynexis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi-Aventis

2.2.1 Business Overview

2.2.2 Antifungal infection Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi-Aventis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Antifungal infection Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Antifungal infection Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck & Co

2.5.1 Business Overview

2.5.2 Antifungal infection Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck & Co Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Kramer Laboratories

2.6.1 Business Overview

2.6.2 Antifungal infection Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Kramer Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Johnson & Johnson

2.7.1 Business Overview

2.7.2 Antifungal infection Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Johnson & Johnson Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 ID Sigma-Aldrich Corporation

2.8.1 Business Overview

2.8.2 Antifungal infection Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Glenmark Pharmaceuticals

2.9.1 Business Overview

2.9.2 Antifungal infection Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Glaxosmithkline

2.10.1 Business Overview

2.10.2 Antifungal infection Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Glaxosmithkline Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.11 Enzon Pharmaceuticals

2.11.1 Business Overview

2.11.2 Antifungal infection Therapeutics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.12 Bayer Healthcare

2.12.1 Business Overview

2.12.2 Antifungal infection Therapeutics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Bayer Healthcare Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.13 Astellas Pharma

2.13.1 Business Overview

2.13.2 Antifungal infection Therapeutics Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Astellas Pharma Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.14 Asperqillus

2.14.1 Business Overview

2.14.2 Antifungal infection Therapeutics Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Asperqillus Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.15 Alternaria

2.15.1 Business Overview

2.15.2 Antifungal infection Therapeutics Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Alternaria Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.16 Abbott Laboratories

2.16.1 Business Overview

2.16.2 Antifungal infection Therapeutics Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Abbott Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antifungal infection Therapeutics Market Competition, by Players

3.1 Global Antifungal infection Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Antifungal infection Therapeutics Players Market Share

3.2.2 Top 10 Antifungal infection Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Antifungal infection Therapeutics Market Size by Regions

4.1 Global Antifungal infection Therapeutics Revenue and Market Share by Regions

4.2 North America Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Antifungal infection Therapeutics Revenue by Countries

5.1 North America Antifungal infection Therapeutics Revenue by Countries (2013-2018)

5.2 USA Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Antifungal infection Therapeutics Revenue by Countries

6.1 Europe Antifungal infection Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Antifungal infection Therapeutics Revenue by Countries

7.1 Asia-Pacific Antifungal infection Therapeutics Revenue by Countries (2013-2018)

7.2 China Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Antifungal infection Therapeutics Revenue by Countries

8.1 South America Antifungal infection Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Antifungal infection Therapeutics by Countries

9.1 Middle East and Africa Antifungal infection Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Antifungal infection Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Antifungal infection Therapeutics Market Segment by Type

10.1 Global Antifungal infection Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Antifungal infection Therapeutics Market Forecast by Type (2018-2023)

10.3 Polyenes Revenue Growth Rate (2013-2023)

10.4 Echinocandins Revenue Growth Rate (2013-2023)

10.5 Azoles Revenue Growth Rate (2013-2023)

10.6 Allylamines Revenue Growth Rate (2013-2023)

10.7 Other Drug types Revenue Growth Rate (2013-2023)

11 Global Antifungal infection Therapeutics Market Segment by Application

11.1 Global Antifungal infection Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Antifungal infection Therapeutics Market Forecast by Application (2018-2023)

11.3 Powders Revenue Growth (2013-2018)

11.4 Pastes Revenue Growth (2013-2018)

11.5 Ointments Revenue Growth (2013-2018)

11.6 Drugs Revenue Growth (2013-2018)

11.7 Other Applications Revenue Growth (2013-2018)

12 Global Antifungal infection Therapeutics Market Size Forecast (2018-2023)

12.1 Global Antifungal infection Therapeutics Market Size Forecast (2018-2023)

12.2 Global Antifungal infection Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Antifungal infection Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Antifungal infection Therapeutics Picture

Table Product Specifications of Antifungal infection Therapeutics

Table Global Antifungal infection Therapeutics and Revenu

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery